Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 21, 2020JAMA Internal MedicineOpen Access

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020

View Full Paper
Ask AI
Bookmark
Share

Authors

FHFiona P. HaversCenters for Disease Control and PreventionCRCarrie ReedIntermountain HealthcareTLTravis LimGilead Sciences (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Havers et al. (2020) studied this question.

synapsesocial.com/papers/6a0dcdc388250cfcc2a52b2dhttps://doi.org/10.1001/jamainternmed.2020.4130
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Universal Screening for SARS-CoV-2 in Women Admitted for Delivery2020 · 1,113 citations
  2. 2Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)2020 · 1,730 citations
  3. 3Interpreting Diagnostic Tests for SARS-CoV-22020 · 1,629 citations
  4. 4Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 20202020 · 459 citations
  5. 5Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility — King County, Washington, March 20202020 · 1,158 citations